SC 13G

Company

SANGAMO THERAPEUTICS, INC

Filed

November 13, 2012

Accession Number

0001144204-12-061674

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →